Search
BioLine RX Ltd
BLRXAdd to Watchlist
3.285USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
14.29MMarket Cap
LossP/E TTM
BioLine RX Ltd's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of BioLine RX Ltd is 9.96, ranking 3 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.68, which is -88.54% below the recent high of -0.77 and -30345.32% above the recent low of -2032.77.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.